Baxter International Inc.Baxter International Inc.Baxter International Inc.

Baxter International Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪17.27 B‬USD
−0.46USD
‪−226.00 M‬USD
‪14.81 B‬USD
‪507.31 M‬
Beta (1Y)
0.92

About Baxter International Inc.

CEO
José E. Almeida
Website
Headquarters
Deerfield
Employees (FY)
‪60 K‬
Founded
1931
FIGI
BBG000BCVJ77
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BAX is 33.90 USD — it has decreased by 0.29% in the past 24 hours. Watch Baxter International Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Baxter International Inc. stocks are traded under the ticker BAX.
BAX stock has fallen by 3.64% compared to the previous week, the month change is a 16.87% fall, over the last year Baxter International Inc. has showed a 18.37% decrease.
We've gathered analysts' opinions on Baxter International Inc. future price: according to them, BAX price has a max estimate of 54.00 USD and a min estimate of 38.00 USD. Watch BAX chart and read a more detailed Baxter International Inc. stock forecast: see what analysts think of Baxter International Inc. and suggest that you do with its stocks.
BAX reached its all-time high on Apr 20, 2020 with the price of 95.19 USD, and its all-time low was 1.11 USD and was reached on Feb 14, 1968. View more price dynamics on BAX chart.
See other stocks reaching their highest and lowest prices.
BAX stock is 1.79% volatile and has beta coefficient of 0.92. Track Baxter International Inc. stock price on the chart and check out the list of the most volatile stocks — is Baxter International Inc. there?
Today Baxter International Inc. has the market capitalization of ‪17.27 B‬, it has decreased by 8.95% over the last week.
Yes, you can track Baxter International Inc. financials in yearly and quarterly reports right on TradingView.
Baxter International Inc. is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
BAX earnings for the last quarter are 0.65 USD per share, whereas the estimation was 0.61 USD resulting in a 7.01% surprise. The estimated earnings for the next quarter are 0.66 USD per share. See more details about Baxter International Inc. earnings.
Baxter International Inc. revenue for the last quarter amounts to ‪3.59 B‬ USD despite the estimated figure of ‪3.55 B‬ USD. In the next quarter revenue is expected to reach ‪3.75 B‬ USD.
BAX net income for the last quarter is ‪37.00 M‬ USD, while the quarter before that showed ‪253.00 M‬ USD of net income which accounts for −85.38% change. Track more Baxter International Inc. financial stats to get the full picture.
Yes, BAX dividends are paid quarterly. The last dividend per share was 0.29 USD. As of today, Dividend Yield (TTM)% is 3.42%. Tracking Baxter International Inc. dividends might help you take more informed decisions.
As of May 26, 2024, the company has ‪60.00 K‬ employees. See our rating of the largest employees — is Baxter International Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Baxter International Inc. EBITDA is ‪2.73 B‬ USD, and current EBITDA margin is 19.33%. See more stats in Baxter International Inc. financial statements.
Like other stocks, BAX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Baxter International Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Baxter International Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Baxter International Inc. stock shows the sell signal. See more of Baxter International Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.